Loading clinical trials...
Loading clinical trials...
The objective of the BELGICA trial is to evaluate if radiotherapy could be given in a more focused manner in patients with glioblastoma in order to reduce side effects and improve quality of life. Th...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Collaborators
NCT05969860 · Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, and more
NCT02800486 · Glioblastoma, Anaplastic Astrocytoma, and more
NCT05789394 · Recurrent Glioblastoma, IDH-Wildtype, Recurrent Astrocytoma, IDH-Mutant, Grade 4, and more
NCT06934889 · Glioblastoma, Gliosarcoma
NCT05839379 · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and more
Olv Azorg
Aalst
EpiCURA
Baudour
AZ Sint Jan
Bruges
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions